News

March 10, 2020

ENDRA Life Sciences Receives CE Mark for its TAEUS® Clinical Product Targeting Non-Alcoholic Fatty Liver Disease

March 06, 2020

ENDRA Life Sciences Granted Chinese Patent for "Thermoacoustic Imaging Probe"

March 03, 2020

Dr. Raza Malik joins ENDRA Life Sciences as Scientific Advisor

February 13, 2020

Sernova Achieves Positive Efficacy Endpoint in Phase I/II Clinical Trial for Type 1 Diabetes

February 10, 2020

Sernova Announces Positive DSMB Review and Recommendation for Continuation of Phase I/II Diabetes Clinical Trial of Cell Pouch™

November 06, 2019

Comet Bio Achieves Self-Affirmed GRAS Status for its PREbiotic Arabinoxylan Plant Fiber Extract, Arrabina™

November 01, 2019

Announcement: Acting Chief Administrative Officer appointment

October 10, 2019

Comet Bio Launches Upcycled Arabinoxylan PREbiotic Dietary Fiber ahead of SupplySide West

October 15, 2019

A novel system to modulate the composition of the microbiome

May 22, 2020

CARL revolutionizing audiology education

September 10, 2019

Sernova Completes Oversubscribed Private Placement of $4,684,564

September 10, 2019

ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at the EASL Non-Alcoholic Fatty Liver Disease Summit in Seville, Spain on September 26-28, 2019

August 07, 2019

TechAlliance Welcomes Christina Fox as CEO

June 27, 2019

Sernova’s Principal Investigator to Present Interim Data from the Company’s Ongoing Phase I/II Cell Pouch Clinical Trial at the 17th World Congress of the International Pancreas and Islet Transplant Association

June 09, 2019

Second cannabis company puts down roots in Aylmer facility

June 03, 2019

Comet Bio Sweeterra™ Syrups Win Institute of Food Technologists 2019 Innovation Award

May 21, 2019

Sernova Corp Announces Appointment of Deborah Brown to its Board of Directors

April 23, 2019

Renix Successfully Commissions the Demonstration RenixUIX™ Unit

April 16, 2019

Western Medical Innovation Fellows awarded two BURST funds

February 11, 2019

Sernova Corp Announces First Patient Implanted with Sernova’s Cell Pouch™ in a Phase I/II US Clinical Trial for the Treatment of Hypoglycemia Unawareness in Subjects with Type 1 Diabetes

May 22, 2020

Sernova Announces Biotech Veteran as New Chief Financial Officer

October 16, 2019

Sernova Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in its Phase I/II Clinical Trial for Type-1 Diabetes

December 18, 2019

Motif Labs secures additional growth financing and announces extraction agreement with cultivator JC Green

February 04, 2019

SWO Angels Investee, Topspin Technologies, Wins NFL’s First and Future Prize

January 31, 2019

Ivey Publishing Announces Best-Selling Cases of January 2019

January 30, 2019

Sernova Announces the Appointment of Dr. David Lillicrap, M.D. to its Scientific Advisory Board

January 17, 2019

News and Events